1. SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells
   Shira Ashkenazi et al, 2016, Oncotarget CrossRef
2. A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
   Mark Kidd et al, 2018, Oncotarget CrossRef
3. Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers?
   Mattia Branca et al, 2018, Melanoma Research CrossRef
4. Prognostic implication of CEACAM1 expression in squamous cell carcinoma of the larynx: Pilot study
   Guendalina Lucarini et al, 2019, Head & Neck CrossRef
5. Novel immune check point inhibiting antibodies in cancer therapy—Opportunities and challenges
   Yael Diesendruck et al, 2017, Drug Resistance Updates CrossRef
6. EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner
   Azadeh Arabzadeh et al, 2017, Oncotarget CrossRef
7. Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells
   Karin Kfir-Elirachman et al, 2018, Neoplasia CrossRef
8. Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1
   Akram Obiedat et al, 2019, The FASEB Journal CrossRef
9. CEACAM1: Expression and Role in Melanocyte Transformation
   Gabriela Turcu et al, 2016, Disease Markers CrossRef
10. Adoptive T cell therapy: An overview of obstacles and opportunities
    Erez Nissim Baruch et al, 2017, Cancer CrossRef